2Deepak L. Bhatt, MD P. Gabriel Steg, MD E. Magnus Ohman, MD Alan T. Hirsch, MD Yasuo Ikeda, MD Jean-Louis Mas, MD Shinya Goto, MD Chlau-Suong Liau, MD, PhD Alain J. Richard, MD, PhD Joachim Roether, MD Peter W. F. Wilson, MD 徐成斌（译）.世界各地动脉粥样硬化血栓形成门诊患者心血管危险因素的流行及诊治情况[J].美国医学会杂志（中文版）,2007,26(1):12-19. 被引量：5
二级参考文献38
1Expert Panel on Detection,Evaluation,and Treatment of High Blood Chlesterol in Adules.Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation,And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel Ⅲ). JAMA,2001,285:2486-2497.
2Grundy SM, Cleeman JI, Merz CN, et al . Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation, 2004 , 110:227-239.
3Bhatt DL, Roe MT, Peterson ED, et al. Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative. JAMA. 2004;292:2096-2104.
4Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practices, and inhospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events(GRACE). Am J Cardiol. 2002;90:358-363.
5Fox KA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G. The European Network for Acute Coronary Treatment (ENACT) study: a pan-European survey of acute coronary syndromes. Eur Heart J. 2000;21:1440-1449.
6Eagle KA, Kline-Rogers E, Goodman SG, et al. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study. Am J Med. 2004; 117:73-81.
7Antiplatelet Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
8US Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med. 2002;136:157-160.
9Heart Protection Study Investigators. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
10CAPRIE SteeringCommittee.A randomised, blinded,trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329-1339.
